Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
18 Nov 2026Braveheart Bio, Inc.BHB-1893 vs. Placebo for Symptomatic Non-obstructive Hypertrophic CardiomyopathyPhase 3Not Yet Recruiting18 Nov 2026GlaxoSmithKlineA Study of Risvutatug Rezetecan in Combination With Atezolizumab in Participants With Extensive Stage Small Cell Lung Cancer (EMBOLD-SCLC-303)Phase 3Not Yet Recruiting18 Nov 2026Interlude Biopharma Co.Clinical Trial to Evaluate the Protective Effect of Larazotide Acetate in Individuals With Well-Controlled Celiac DiseasePhase 3Not Yet Recruiting18 Nov 2026Longbio PharmaChinaA Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite Treatment With H1 AntihistaminesPhase 3Not Yet Recruiting18 Nov 2026Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.ChinaDiagnostic Performance and Safety of Ragweed Pollen and Dog Dander Skin Prick Test SolutionsPhase 3Not Yet Recruiting17 Nov 2026Boryung Biopharma Co., Ltd.South KoreaA Study to Evaluate the Efficacy and Safety of BRC-201 in Patients With Acute Uncomplicated InfluenzaPhase 3Recruiting17 Nov 2026Bristol-Myers SquibbA Study to Evaluate the Safety and Efficacy of Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM)Phase 3Not Yet Recruiting17 Nov 2026Reinovax Biologics Co., LTDChinaA Phase Ⅲ Clinical Trial of an Investigative 24-valent Pneumococcal Polysaccharide Conjugate VaccinePhase 3Not Yet Recruiting17 Nov 2026SanofiStudy of Hexaxim Compared With Pentaxim Administered With a Monovalent Hepatitis B Vaccine in Healthy Chinese Infants.Phase 3Not Yet Recruiting17 Nov 2026Tasly Biopharmaceuticals Co., Ltd.ChinaIntravenous Recombinant Human Prourokinase (rhPro-UK) for Acute Ischemic Stroke Within 4.5 to 24 Hours of OnsetPhase 3Not Yet Recruiting16 Nov 2026Dexa Medica GroupIndonesiaThe Efficacy and Safety of DLBS3233 in Adults With PrediabetesPhase 3Completed16 Nov 2026Hoffmann-La RocheA Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants With Multiple Sclerosis (MS)Phase 3Not Yet Recruiting16 Nov 2026Novartis PharmaceuticalsA Study to Assess the Effect of Pacibekitug on Major Cardiovascular Events in Patients After a Myocardial InfarctionPhase 3Not Yet Recruiting13 Nov 2026AstraZenecaAn Efficacy and Safety Study to Assess an Inhaled, Fixed-dose, Budesonide/Formoterol Fumarate in Participants Aged 4 to Less Than 12 Years of Age With Moderate Persistent AsthmaPhase 3Not Yet Recruiting13 Nov 2026Hemab ApSUnited StatesA Phase 3 Evaluation of Sutacimig in Glanzmann ThrombastheniaPhase 3Recruiting13 Nov 2026RemeGen Co., Ltd.ChinaIIIb Trial for RC28-E Injection in Participants With DME and wAMDPhase 3Not Yet Recruiting12 Nov 2026Aponia Laboratories, Inc.United States, GermanyEffect of S-Ibuprofen Gel on Pain in Acute Soft Tissue ContusionsPhase 3Recruiting12 Nov 2026AstraZenecaChina, Hong Kong, MalaysiaA Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve PatientsPhase 3Not Yet Recruiting12 Nov 2026Daewon Pharmaceutical Co., Ltd.South KoreaClinical Trial to Evaluate the Safety and Efficacy of DW4421 in Patients With Erosive Reflux DiseasePhase 3Completed12 Nov 2026Novo Nordisk A/SUnited States, Argentina, BrazilA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or BothPhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, China, JapanA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and ExercisePhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Brazil, ChinaA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting12 Nov 2026PfizerThe Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or OverweightPhase 3Not Yet Recruiting12 Nov 2026Qilu Pharmaceutical Co., Ltd.A Study in Participants With Relapsed or Refractory Multiple Myeloma for QLS4131Phase 3Not Yet Recruiting12 Nov 2026SanofiA Study to Investigate Long-term Safety and Tolerability of Frexalimab in Participants With Multiple SclerosisPhase 3Not Yet Recruiting12 Nov 2026Telix Pharmaceuticals (Innovations) Pty Limited[18F]FET PET for Differentiating Tumor Progression vs Treatment-Related Changes in Brain MetastasesPhase 3Not Yet Recruiting10 Nov 2026Boehringer IngelheimBelgium, France, GermanyA Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With ObrixtamigPhase 3Not Yet Recruiting10 Nov 2026ISTx, LLCA Study of Ceftobiprole Compared With Standard Antibiotic Treatment in Children With Staphylococcus Aureus Bacteremia (SAB) Infection, Including Right-sided Heart InfectionPhase 3Not Yet Recruiting10 Nov 2026MedicureUnited States, AustraliaContinuation Study With Oral MC-1 for Treatment of Patients With PNPO-DeficiencyPhase 3Recruiting10 Nov 2026Polisorb Joint Stock CompanyRussiaEfficacy and Safety of Polisorb® MP in the Complex Therapy of Patients With Atopic DermatitisPhase 3Completed10 Nov 2026SanofiThe Efficacy and Safety of Venglustat Compared With Cerezyme in Pediatric Participants 2 to 11 Years of Age With Gaucher Disease Type 3 (GD3)Phase 3Not Yet Recruiting9 Nov 2026Ascendis Pharma A/SClinical Trial Evaluating the Efficacy and Safety of Navepegritide and Lonapegsomatropin in AchondroplasiaPhase 3Not Yet Recruiting9 Nov 2026Beijing InnoCare Pharma Tech Co., Ltd.ChinaA Study Comparing Mesutoclax + Azacitidine Versus Venetoclax + Azacitidine in Untreated Acute Myeloid Leukemia (AML) PatientsPhase 3Recruiting9 Nov 2026CSPC Megalith Biopharmaceutical Co.,Ltd.ChinaA Study of SYS6010 Combined With Enlonstobart in Patients With Previously Systemic Treatment-Naive R/M Nasopharyngeal CarcinomaPhase 3Recruiting9 Nov 2026CSPC Megalith Biopharmaceutical Co.,Ltd.A Randomized, Controlled, Double-Blind, Multicenter Phase III Clinical Trial to Evaluate the Efficacy and Safety of Enlonstobart, With or Without SYS6010 as Adjuvant Therapy, in Participants With Pathologically Residual Esophageal Squamous Cell Carcinoma Following Complete Surgical ResectionPhase 3Not Yet Recruiting9 Nov 2026PfizerUnited StatesA Study to Assess the Safety of Marstacimab and How Well it Works in People With Mild to Moderate Hemophilia A or B Without InhibitorsPhase 3Recruiting9 Nov 2026Qilu Pharmaceutical Co., Ltd.A Study of QLS5132 in Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerPhase 3Not Yet Recruiting6 Nov 2026AstraZenecaChina, IndiaA Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 DiabetesPhase 3Not Yet Recruiting6 Nov 2026Jiangsu HengRui Medicine Co., Ltd.ChinaEfficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 DiabetesPhase 3Not Yet Recruiting5 Nov 2026Hoffmann-La RocheA Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular DiseasePhase 3Not Yet Recruiting5 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityPhase 3Not Yet Recruiting5 Nov 2026PfizerUnited States, CanadaA Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)Phase 3Recruiting5 Nov 2026SanofiPharmacokinetics, Immunogenicity and Safety of Subcutaneous Dupilumab and Berahyaluronidase Alfa (ALT-B4) CoformulationPhase 3Not Yet Recruiting4 Nov 2026Arcutis Biotherapeutics, Inc.United StatesRoflumilast Cream 0.3% for Moderate to Severe Atopic DermatitisPhase 3Recruiting4 Nov 2026Ascendis Pharma A/SA Clinical Trial to Evaluate Efficacy and Safety of Navepegritide Versus Placebo in Children and Adolescents With HypochondroplasiaPhase 3Not Yet Recruiting4 Nov 2026Boehringer IngelheimUnited States, Argentina, AustriaA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Phase 3Not Yet Recruiting4 Nov 2026Colgate PalmoliveDominican RepublicEfficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and GingivitisPhase 3Completed4 Nov 2026Innovent Biologics (Suzhou) Co. Ltd.ChinaSintilimab Combined With LCCRT Followed by Capeox Chemotherapy in pMMR/MSS/MSI-L Locally Advanced Rectal CancerPhase 3Not Yet Recruiting4 Nov 2026PfizerUnited StatesA Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)Phase 3Recruiting// How AOS uses this